The Efficacy of Autologous Nebulized Platelet Rich Plasma (PRP) As an Early Adjuvant Therapeutic and Prognostic Treatment Modality in the Management of Inhalation Lung Injury

Abstract

Background: Despite considerable advances in our knowledge of the pathophysiology of inhalation injury, there are few specific therapeutic options, and patient care is mainly supportive. Platelets release growth factors and other immune system components to start healing process. By using nebulized Platelet Rich Plasma (PRP), platelets may reduce inflammation and stimulates bronchial tree healing. However, there are no clear data supporting or refuting the use of inhaled PRP in inhalation injury.